Gilead Sciences Added to the Dow Jones Sustainability World Index

Nov 30, 2021 8:55 AM ET

Campaign: Corporate Social Responsibility

We’re proud to be added to the Dow Jones Sustainability World Index, part of S&P Global Dow Jones Indices, based on our performance on the Corporate Sustainability Assessment. The assessment reflects our ongoing commitment to be a leader in this area as we work to discover, develop and deliver innovative therapeutics for people with life-threatening diseases.

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

Here's a link to the Dow Jones news release.

Gilead Sciences Added to the Dow Jones Sustainability World Index

More from Gilead Sciences

Gilead Helps Pen a Children’s Book for Families Facing Breast Cancer

Gilead Foundation’s Healthcare Education, Access and Leadership (HEAL) Initiative Is Dedicating $5 Million to Help Build a More Diverse Bay Area Healthcare Workforce

Gilead Oncology Grant Supports 22 U.S. Organizations With $3.15 Million to Provide Support to Those Affected By Breast Cancer

Gilead Sciences: New Report Shows Every Country in the World Must Do More To End the HIV Epidemic

Championing HIV Services for LGBTQ+ Youth

Working to Build Next-Generation Cancer Therapies

Helping End HIV - Gilead Sciences

Seramount Ranks Gilead Sciences Among Its Leading Inclusion Index Company